OSI

R&D

The future of drug development: Integrating open source and ...

Clinical trials for drug development are becoming increasingly complex, with numerous variables that must be identified and defined from the start.

Deep Dive

The promise and pitfalls of molecular testing in oncology

Great strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain that frustrate both physicians and patients.

News

Ex-BioNTech execs launch 'AI-native' cancer company

Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks